From fate to tragedy: the changing meanings of life, death, and AIDS

Selwyn, Peter A.; Selwyn, P A; Arnold, R
December 1998
Annals of Internal Medicine;12/01/98, Vol. 129 Issue 11, p899
Academic Journal
journal article
The advent of highly active antiretroviral therapy (HAART) and quantitative viral load assays has revolutionized the care of HIV-infected patients. However, this paradigm shift has also had unexpected, sometimes adverse consequences that are not always obvious. Before antiretroviral therapy, physicians learned how to accompany patients through their illness; to bear witness to sickness and dying; and to help patients and their families with suffering, closure, and legacy. Since we have become better at treating the virus, a new temptation has emerged to dwell on quantitative aspects of HIV management and monitoring, although the skills that we learned earlier in the epidemic are no less necessary for providing good care. Our new-found therapeutic capabilities should not distract us from the sometimes more difficult and necessary task of simply "being there" for patients for whom HAART is no longer effective. The definition and practice of end-of-life care for patients with AIDS will continue to evolve as AIDS comes to resemble other chronic, treatable, but ultimately fatal illnesses, such as end-stage pulmonary disease and metastatic cancer, in which clinicians must continually readdress with their patients the balance of curative and palliative interventions as the disease process unfolds over time. The coming challenge in HIV care will be to encourage the maintenance of a "primary care" mentality-with attention to the larger psychosocial issues, end-of-life care, bereavement, and a focus on the patient as opposed to the illness-alongside our new antiretroviral paradigm. Otherwise, we run the risk of forgetting what we learned about healing, from a disease that we could not cure.


Related Articles

  • Illustrations and implications of current models of HIV health service provision in rural areas. Mainous III, Arch G.; Noble, Robert C. // AIDS Patient Care & STDs;Feb1997, Vol. 11 Issue 1, p25 

    Discusses the implications of HIV/AIDS health-care delivery models in the rural areas in the United States. HIV epidemic in the rural areas; Evidence of patients splitting health care into HIV care; Case histories of models of HIV-related health care.

  • Housing status and health care service utilization among low-income persons with HIV/AIDS. Smith, Meredith Y.; Rapkin, Bruce D.; Winkel, Gary; Springer, Carolyn; Chhabra, Rosy; Feldman, Ira S.; Smith, M Y; Rapkin, B D; Winkel, G; Springer, C; Chhabra, R; Feldman, I S // JGIM: Journal of General Internal Medicine;Oct2000, Vol. 15 Issue 10, p731 

    Objective: To examine the impact of housing status on health service utilization patterns in low-income HIV-infected adults.Design: A survey of 1,445 HIV-infected Medicaid recipients in New York State between April 1996 and March 1997.Main Results: Six...

  • Sources of evidence in HIV/AIDS care: pilot study comparing family physicians and AIDS service organization staff. Stefanski, Kasia E.; Tracy, C. Shawn; Upshur, Ross E. G. // BMC Health Services Research;2004, Vol. 4, p18 

    Background: The improvement of the quality of the evidence used in treatment decision-making is especially important in the case of patients with complicated disease processes such as HIV/AIDS for which multiple treatment strategies exist with conflicting reports of efficacy. Little is known...

  • Complementary therapy use among HIV-Infected patients. Bates, Buddy R.; Kissinger, Patricia // AIDS Patient Care & STDs;Feb1996, Vol. 10 Issue 1, p32 

    Presents information on the use of complementary therapy among HIV-positive patients. Statistics given; Comparison of whites and nonwhites; Frequency and types of therapies used.

  • Clarithromycin and MAC.  // AIDS Patient Care & STDs;Feb1996, Vol. 10 Issue 1, p54 

    Reports on the effects of clarithromycin on patients with advanced HIV infections who have MAC. Results from a study carried out; Those who participated; Implications.

  • Educational materials.  // AIDS Patient Care & STDs;Aug96, Vol. 10 Issue 4, p269 

    Presents an overview of selected books and videos about the care of people with AIDS. `WHO Model Prescribing Information: Drugs Used in Sexually Transmitted Diseases and HIV Infection'; `Living with Dementia: A Guide for the Extended Family' by Fawn Moran; `How to Care for Someone on Bedrest',...

  • Combination Shows Efficacy.  // AIDS Patient Care & STDs;Sep98, Vol. 12 Issue 9, p719 

    Reports that according to preliminary data from a small phase II study, six out of nine HIV-positive patients who received a combination of the investigational drugs abacavir and amprenavir had less than five viral copies per milliliter of plasma, following 48 weeks of treatment. Duration of...

  • Clinical Experience with Human Immunodeficiency Virus-Infected Older Patients in the Era of Effective Antiretroviral Therapy. Grimes, Richard M.; Otiniano, Max E.; Rodriguez-Barradas, Maria C.; Lai, Dejian // Clinical Infectious Diseases;6/1/2002, Vol. 34 Issue 11, p1530 

    Suggests the need to examine whether therapies for HIV-infected patients are as effective in older patients as in younger patients. Result of a study of hemophiliacs; Definition of recommended antiretroviral therapy; Comparison of the clinical and demographic characteristics of HIV-infected...

  • HHS Announces $710 Million in Grants for HIV/AIDS Care. Sweeney, Rosemarie; Rose, Vernal L. // American Family Physician;5/1/1999, Vol. 59 Issue 9, p2403 

    Focuses on the grants released by the United States Health and Human Services to several states to fund primary health care and support services for low-income persons with HIV and AIDS. Overview of the Ryan White Comprehensive AIDS Resources Emergency; Recipients of the grants.

  • Antifungals and resistance.  // AIDS Patient Care & STDs;Feb1996, Vol. 10 Issue 1, p54 

    Presents information from a research done on fungi and its resistance to antifungal drugs. Where most of the resistance have taken place; Impact on HIV-infected persons.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics